BiotechTube
Home/Skeletalis/Thomas P. DeVlaam
TP

Thomas P. DeVlaam

Director, Lead Investor

Skeletalis

Therapeutic Areas

MusculoskeletalOsteoporosis

Skeletalis Pipeline

DrugIndicationPhase
OASIS PlatformOsteoporosis (lead focus)Preclinical

Leadership Team at Skeletalis

WB
W. Benton Swanson, DDS, PhD
Chief Executive Officer, Inventor, Founder
CF
Colin F. Greineder, MD, PhD
Scientific Advisory Board Chair, Inventor, Founder
View full Skeletalis profile